JPH05170603A - Dermatic external preparation composition - Google Patents
Dermatic external preparation compositionInfo
- Publication number
- JPH05170603A JPH05170603A JP3355232A JP35523291A JPH05170603A JP H05170603 A JPH05170603 A JP H05170603A JP 3355232 A JP3355232 A JP 3355232A JP 35523291 A JP35523291 A JP 35523291A JP H05170603 A JPH05170603 A JP H05170603A
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- external preparation
- present
- preparation composition
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
(57)【要約】
【目的】 本発明は、有害生物忌避効果の持続性に優れ
た皮膚外用剤組成物の提供を目的とする。
【構成】 ジエチルトルアミドと、ベンゾフェノン誘導
体、ケイヒ酸誘導体、パラアミノ安息香酸誘導体、サリ
チル酸誘導体、ジベンゾイルメタン誘導体、及びベンツ
イミダゾール誘導体から選ばれる化合物の一種又は二種
以上とを組み合わせて配合することを特徴とする皮膚外
用剤組成物。(57) [Summary] [Object] An object of the present invention is to provide a skin external preparation composition having excellent durability of pest repellent effect. [Structure] Mixing and blending diethyltoluamide with one or more compounds selected from a benzophenone derivative, a cinnamic acid derivative, a paraaminobenzoic acid derivative, a salicylic acid derivative, a dibenzoylmethane derivative, and a benzimidazole derivative. A characteristic external preparation composition for skin.
Description
【0001】[0001]
【産業上の利用分野】本発明は、ジエチルトルアミドの
有する有害生物忌避効果の持続性に優れた皮膚外用剤組
成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin external preparation composition having excellent persistence of the pest repellent effect of diethyltoluamide.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】蚊等の
有害生物から身を守るための有害生物忌避剤として、ジ
エチルトルアミドが広く用いられている。しかしなが
ら、このジエチルトルアミドは忌避効果は高いものの、
効果の持続性に欠け更に改良が求められていた。そこで
本発明の目的は、忌避効果の持続性に優れた皮膚外用剤
組成物を提供することにある。BACKGROUND OF THE INVENTION Diethyltoluamide is widely used as a pest repellent for protecting oneself from pests such as mosquitoes. However, although this diethyltoluamide has a high repellent effect,
The effect was lacking in sustainability and further improvement was required. Therefore, an object of the present invention is to provide a skin external preparation composition having excellent sustainability of repellent effect.
【0003】[0003]
【課題を解決しようとする手段】本発明者らは上記事情
に鑑み、ジエチルトルアミドの持続性を高めるべく鋭意
研究した結果、ジエチルトルアミドと、更にベンゾフェ
ノン誘導体、ケイヒ酸誘導体、パラアミノ安息香酸誘導
体、サリチル酸誘導体、ジベンゾイルメタン誘導体及び
ベンツイミダゾール誘導体から選ばれる化合物の一種又
は二種以上とを組み合わせて配合することで効果の持続
性が高まることを見いだし、本発明を完成するに至っ
た。SUMMARY OF THE INVENTION In view of the above circumstances, the inventors of the present invention have conducted extensive studies to improve the durability of diethyltoluamide, and as a result, diethyltoluamide, and further benzophenone derivatives, cinnamic acid derivatives, and paraaminobenzoic acid derivatives have been developed. The present invention has been completed by discovering that the sustainability of the effect is enhanced by combining and combining one or more compounds selected from salicylic acid derivatives, dibenzoylmethane derivatives and benzimidazole derivatives, and completed the present invention.
【0004】即ち、本発明は、ジエチルトルアミドと、
ベンゾフェノン誘導体、ケイヒ酸誘導体、パラアミノ安
息香酸誘導体、サリチル酸誘導体、ジベンゾイルメタン
誘導体、及びベンツイミダゾール誘導体から選ばれる化
合物の一種又は二種以上とを組み合わせて配合すること
を特徴とする皮膚外用剤組成物である。That is, the present invention relates to diethyltoluamide and
A skin external preparation composition comprising a combination of one or more compounds selected from benzophenone derivatives, cinnamic acid derivatives, paraaminobenzoic acid derivatives, salicylic acid derivatives, dibenzoylmethane derivatives, and benzimidazole derivatives. Is.
【0005】本発明に用いられるジエチルトルアミド
は、従来より有害生物忌避剤として用いられているもの
で、試薬あるいは工業用原料として汎用されているもの
である。その配合量は最終組成物の剤型、使用条件によ
り異なるが、最終組成物の総量を基準に0.01〜9
0.0重量%、好ましくは1〜20重量%の範囲で用い
られる。The diethyltoluamide used in the present invention has been conventionally used as a pest repellent, and is widely used as a reagent or an industrial raw material. The blending amount varies depending on the formulation of the final composition and the use conditions, but is 0.01 to 9 based on the total amount of the final composition.
It is used in an amount of 0.0% by weight, preferably 1 to 20% by weight.
【0006】本発明に用いられるベンゾフェノン誘導体
としては、2−ヒドロキシ−4−メトキシベンゾフェノ
ン、2−ヒドロキシ−4−メトキシベンゾフェノン−5
−スルホン酸及びその塩類、2,2’−ジヒドロキシ−
4−メトキシベンゾフェノン、2,4−ジヒドロキシベ
ンゾフェノン、2,2’,4,4’−テトラヒドロキシ
ベンゾフェノン、2,2’−ジヒドロキシ−4,4’−
ジメトキシベンゾフェノン、2−ヒドロキシ−4−オク
トキシベンゾフェノン等が挙げられる。The benzophenone derivative used in the present invention includes 2-hydroxy-4-methoxybenzophenone and 2-hydroxy-4-methoxybenzophenone-5.
-Sulfonic acid and its salts, 2,2'-dihydroxy-
4-methoxybenzophenone, 2,4-dihydroxybenzophenone, 2,2 ', 4,4'-tetrahydroxybenzophenone, 2,2'-dihydroxy-4,4'-
Examples thereof include dimethoxybenzophenone and 2-hydroxy-4-octoxybenzophenone.
【0007】本発明に用いられるケイヒ酸誘導体として
は、p−メトキシケイヒ酸2−エチルヘキシルエステ
ル、p−メトキシケイヒ酸ジエタノールアミン塩、ジ−
p−メトキシケイヒ酸−モノ−2−エチルヘキサン酸グ
リセリル等が挙げられる。As the cinnamic acid derivative used in the present invention, p-methoxycinnamic acid 2-ethylhexyl ester, p-methoxycinnamic acid diethanolamine salt, di-
P-methoxycinnamic acid-glyceryl mono-2-ethylhexanoate and the like can be mentioned.
【0008】本発明に用いられるパラアミノ安息香酸誘
導体としては、4−ビス−(2−ヒドロキシプロピル)
−アミノ安息香酸エチルエステル、p−アミノ安息香酸
1,2,3−プロパントリオールエステル、p−ジメチ
ルアミノ安息香酸オクチルエステル、p−アミノ安息香
酸等が挙げられる。The para-aminobenzoic acid derivative used in the present invention is 4-bis- (2-hydroxypropyl).
-Aminobenzoic acid ethyl ester, p-aminobenzoic acid 1,2,3-propanetriol ester, p-dimethylaminobenzoic acid octyl ester, p-aminobenzoic acid and the like can be mentioned.
【0009】本発明に用いられるサリチル酸誘導体とし
ては、サリチル酸2−エチルヘキシルエステル、サリチ
ル酸3,3,5−トリメチルシクロヘキシルエステル、
サリチル酸トリエタノールアミド等が挙げられる。The salicylic acid derivative used in the present invention includes salicylic acid 2-ethylhexyl ester, salicylic acid 3,3,5-trimethylcyclohexyl ester,
Examples include salicylic acid triethanolamide.
【0010】本発明に用いられるジベンゾイルメタン誘
導体としては、1−p−クメニル−3−フェニルプロパ
ン−1,3−ジオン、4−t−ブチル−4’−メトキシ
ジベンゾイルメタン等が挙げられる。Examples of the dibenzoylmethane derivative used in the present invention include 1-p-cumenyl-3-phenylpropane-1,3-dione and 4-t-butyl-4'-methoxydibenzoylmethane.
【0011】本発明に用いられるベンツイミダゾール誘
導体としては、2−フェニル−ベンツイミダゾール−5
−スルホン酸及びその塩類等が挙げられる。The benzimidazole derivative used in the present invention is 2-phenyl-benzimidazole-5.
-Sulfonic acid and its salts are mentioned.
【0012】本発明に用いられるベンゾフェノン誘導
体、ケイヒ酸誘導体、パラアミノ安息香酸誘導体、サリ
チル酸誘導体、ジベンゾイルメタン誘導体及びベンツイ
ミダゾール誘導体の一種又は二種以上の配合量は、最終
組成物の剤型・使用条件により異なるが、最終組成物の
総量を基準に0.001〜20.0重量%の範囲であ
り、好ましくは1〜15重量%である。The benzophenone derivative, the cinnamic acid derivative, the paraaminobenzoic acid derivative, the salicylic acid derivative, the dibenzoylmethane derivative and the benzimidazole derivative used in the present invention may be blended in one or two or more types depending on the formulation and use of the final composition. Although it depends on the conditions, it is in the range of 0.001 to 20.0% by weight, preferably 1 to 15% by weight, based on the total amount of the final composition.
【0013】本発明の皮膚外用剤組成物は、軟膏剤、ク
リーム、乳液、化粧水、香水、コロン、スプレー剤等の
剤型で用いられる。The external preparation for skin of the present invention is used in the form of ointments, creams, emulsions, lotions, perfumes, colognes, sprays and the like.
【0014】本発明の皮膚外用剤組成物には、本発明の
目的を達成する範囲で剤型に応じて他の基剤及び添加剤
を配合することができる。The external preparation for skin of the present invention may contain other bases and additives depending on the dosage form within the range in which the object of the present invention is achieved.
【0015】[0015]
【実施例】以下、実施例にて本発明を詳細に説明する。
尚、実施例中のwt%は重量%を意味する。EXAMPLES The present invention will be described in detail below with reference to examples.
In the examples, wt% means wt%.
【0016】実施例に先だって、有害生物忌避効果及び
その持続性の試験方法について記載する。 (ヒトスジシマカ成虫に対する吸血忌避試験)ヒトスジ
シマカの成虫に対する忌避効果を調べるために以下の試
験を室温30℃、湿度70%の恒温室において行った。
左右の前腕に各試料10gを塗布した後、羽化後5〜7
日経過したヒトスジシマカの成虫の雌雄50匹づつが入
った20cm×15cmの金網にそれぞれの腕を15分
間差し入れ吸血の時間を与えた。この施行を30分、1
時間、2時間、4時間、6時間後に行い、吸血の時間内
の吸血の跡の数を数え、数1より忌避率を算出した。Prior to the examples, the test method for pest repellent effect and its persistence will be described. (Blood-feeding repellent test for adult Aedes albopictus) In order to investigate the repellent effect of Aedes albopictus on adults, the following test was conducted in a thermostatic chamber at room temperature of 30 ° C. and humidity of 70%.
After applying 10 g of each sample to the left and right forearms, 5-7 after emergence
Each arm was inserted into a 20 cm × 15 cm wire net containing 50 adult male and female Aedes albopictus for 15 minutes to allow blood feeding. 30 minutes for this enforcement, 1
The test was performed after 2 hours, 4 hours, and 6 hours, and the number of blood-sucking traces within the time of blood-sucking was counted, and the repellency rate was calculated from Equation 1.
【数1】 X:試験液を塗布しない場合の吸血の跡の数 Y:試験液を塗布した場合の吸血の跡の数[Equation 1] X: Number of blood-sucking traces when test liquid was not applied Y: Number of blood-sucking traces when test liquid was applied
【0017】実施例1 表1の処方の通り本発明のクリームを常法に従って調製
し、ヒトスジシマカ成虫に対する吸血忌避試験を実施し
た。その結果を表4に示す。Example 1 The cream of the present invention was prepared according to a conventional method according to the formulation shown in Table 1, and a blood-sucking repellent test against adult Aedes albopictus was conducted. The results are shown in Table 4.
【0018】[0018]
【表1】 [Table 1]
【0019】比較例1 表2の処方の通り比較用のクリームを常法に従って調製
し、ヒトスジシマカ成虫に対する吸血忌避試験を実施し
た。その結果を表4に示す。Comparative Example 1 A cream for comparison having the formulation shown in Table 2 was prepared by a conventional method, and a blood-sucking repellent test against adult Aedes albopictus was carried out. The results are shown in Table 4.
【0020】[0020]
【表2】 [Table 2]
【0021】比較例2 表3の処方の通り比較用のクリームを常法に従って調製
し、ヒトスジシマカ成虫に対する吸血忌避試験を実施し
た。その結果を表4に示す。Comparative Example 2 A cream for comparison having the formulation shown in Table 3 was prepared according to a conventional method, and a blood-sucking repellent test against adult Aedes albopictus was conducted. The results are shown in Table 4.
【0022】[0022]
【表3】 [Table 3]
【0023】[0023]
【表4】 [Table 4]
【0024】表4に示した如く、本発明の実施例1は、
塗布後6時間でも忌避効果が低下せず、優れていた。こ
れに対し、ジエチルトルアミドのみを配合した比較例1
は、30分後までは顕著な効果を有するが、時間経過と
ともに効果が失われた。またジエチルトルアミドも配合
しなかった比較例2は、全く忌避効果を示さなかった。As shown in Table 4, the first embodiment of the present invention is
Even after 6 hours from application, the repellent effect did not decrease, and it was excellent. On the other hand, Comparative Example 1 containing only diethyltoluamide
Had a remarkable effect up to 30 minutes, but the effect was lost over time. In addition, Comparative Example 2 in which diethyltoluamide was not added did not show any repellent effect.
【0025】実施例2 表5の処方の通り化粧水を常法に従って調製し、ヒトス
ジシマカ成虫に対する吸血忌避試験を実施した。Example 2 A lotion was prepared according to the conventional method according to the formulation shown in Table 5, and a blood-sucking repellent test was conducted on adults of Aedes albopictus.
【0026】[0026]
【表5】 [Table 5]
【0027】実施例3 表6の処方の通りコロンを常法に従って調製し、ヒトス
ジシマカ成虫に対する吸血忌避試験を実施した。Example 3 Colons were prepared according to the conventional method according to the formulations shown in Table 6, and a blood-sucking repellent test was conducted on adults of Aedes albopictus.
【0028】[0028]
【表6】 [Table 6]
【0029】実施例4 表7の処方の通り乳液を常法に従って調製し、ヒトスジ
シマカ成虫に対する吸血忌避試験を実施した。Example 4 A milky lotion was prepared according to a conventional method according to the formulation shown in Table 7, and a blood-sucking repellent test against adult Aedes albopictus was conducted.
【0030】[0030]
【表7】 [Table 7]
【0031】実施例5 表8の処方の通り軟膏を常法に従って調製し、ヒトスジ
シマカ成虫に対する吸血忌避試験を実施した。Example 5 Ointments having the formulations shown in Table 8 were prepared by a conventional method, and a blood-sucking repellent test against adult Aedes albopictus was conducted.
【0032】[0032]
【表8】 [Table 8]
【0033】実施例6 表9の処方の通りクリームを常法に従って調製し、ヒト
スジシマカ成虫に対する吸血忌避試験を実施した。Example 6 A cream was prepared according to the conventional method according to the formulation in Table 9, and a blood-sucking repellent test against adult Aedes albopictus was conducted.
【0034】[0034]
【表9】 [Table 9]
【0035】実施例2〜6のヒトスジシマカ成虫に対す
る吸血忌避試験結果を表10に示す。表に示した如く、
本発明の実施例2〜6は塗布後6時間でも忌避効果に優
れていた。Table 10 shows the results of the blood-sucking repellent test for adults of Aedes albopictus of Examples 2 to 6. As shown in the table,
Examples 2 to 6 of the present invention were excellent in repellent effect even 6 hours after application.
【0036】[0036]
【表10】 [Table 10]
【0037】[0037]
【発明の効果】以上記載の如く、本発明が、ジエチルト
ルアミドと、ベンゾフェノン誘導体、ケイヒ酸誘導体、
パラアミノ安息香酸誘導体、サリチル酸誘導体、ジベン
ゾイルメタン誘導体及びベンツイミダゾール誘導体から
選ばれる化合物の一種又は二種以上とを組み合わせて配
合することで、有害生物忌避効果の持続性に優れた皮膚
外用剤組成物を提供することは明らかである。INDUSTRIAL APPLICABILITY As described above, according to the present invention, diethyltoluamide, a benzophenone derivative, a cinnamic acid derivative,
A skin external preparation composition having excellent persistence of pest repellent effect by blending in combination with one or more compounds selected from para-aminobenzoic acid derivative, salicylic acid derivative, dibenzoylmethane derivative and benzimidazole derivative. It is clear to provide.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 (A01N 37/18 37:44) (A01N 37/18 31:14) (A01N 37/18 43:52) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Office reference number FI technical display location (A01N 37/18 37:44) (A01N 37/18 31:14) (A01N 37/18 43: 52)
Claims (1)
誘導体、ケイヒ酸誘導体、パラアミノ安息香酸誘導体、
サリチル酸誘導体、ジベンゾイルメタン誘導体及びベン
ツイミダゾール誘導体から選ばれる化合物の一種又は二
種以上とを組み合わせて配合することを特徴とする皮膚
外用剤組成物。1. Diethyltoluamide, a benzophenone derivative, a cinnamic acid derivative, a paraaminobenzoic acid derivative,
A skin external preparation composition comprising a combination of one or more compounds selected from salicylic acid derivatives, dibenzoylmethane derivatives and benzimidazole derivatives.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3355232A JPH05170603A (en) | 1991-12-19 | 1991-12-19 | Dermatic external preparation composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3355232A JPH05170603A (en) | 1991-12-19 | 1991-12-19 | Dermatic external preparation composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH05170603A true JPH05170603A (en) | 1993-07-09 |
Family
ID=18442730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3355232A Pending JPH05170603A (en) | 1991-12-19 | 1991-12-19 | Dermatic external preparation composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH05170603A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998053683A1 (en) * | 1997-05-27 | 1998-12-03 | Karl Engelhard Fabrik Pharm. Präparate Gmbh & Co. Kg | Insect repellent |
-
1991
- 1991-12-19 JP JP3355232A patent/JPH05170603A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998053683A1 (en) * | 1997-05-27 | 1998-12-03 | Karl Engelhard Fabrik Pharm. Präparate Gmbh & Co. Kg | Insect repellent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9314029B2 (en) | Control and repellency of mosquitoes | |
| EP0243308B1 (en) | Stabilization of the preservative thiomersal in ophthalmic pharmaceutical compositions | |
| US4477467A (en) | Insect repellent | |
| EP0085334A2 (en) | Substantive topical compositions | |
| EP0930065A2 (en) | Alcohol based anti-microbial compositions with cosmetic appearance | |
| JPS63174902A (en) | Insect repellent composition and manufacture | |
| US20150133406A1 (en) | Synergistic formulations for control and repellency of biting arthropods | |
| JPS60231604A (en) | Insecticidal aqueous microemulsion composition | |
| DE2708001A1 (en) | DISINFECTANT | |
| HUP0001850A2 (en) | Preservative containing iodopropynyl butyl carbamate and phenoxyethanol | |
| JPH05294828A (en) | Dermal composition for external use | |
| US20190380350A1 (en) | Topical mosquito control product with sunscreen | |
| JPH05170603A (en) | Dermatic external preparation composition | |
| JP3405736B2 (en) | Biting pest repellent | |
| US4612327A (en) | Repellent compositions against insects, ticks and mites employing mixtures of O-alkyl-N-phenylthiocarbamates and Deet | |
| CN101406431A (en) | External-use formulation for preventing bite of mosquito | |
| JPH0592915A (en) | Medicine for external use | |
| US4427700A (en) | Repellent for black fly | |
| JPH05310508A (en) | Dermal external preparation composition | |
| JPH024563B2 (en) | ||
| US2639259A (en) | Insecticides | |
| US2808359A (en) | Insect repellent compositions of hydroxy-alkyl esters of polybasic organic acids and methods of using same | |
| JPH07138102A (en) | Harmful organism repellent | |
| JPH08208403A (en) | External composition for skin | |
| WO2008143376A1 (en) | Mosquito repellent |